Published in Br Med J on October 19, 1974
Problems with immunosuppressive agents in renal disease. J Clin Pathol Suppl (R Coll Pathol) (1975) 0.75
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
RENAL HOMOTRANSPLANTATION IN MAN IN MODIFIED RECIPIENTS. Ann Surg (1963) 4.13
Renal transplantation in man. Experience in 35 cases. Lancet (1969) 3.67
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
De-novo brain tumours in renal-transplant recipients. Lancet (1971) 2.36
Progressive destruction of renal homografts isolated from the regional lymphatics of the host. Surgery (1955) 1.72
Combination chemotherapy for testicular tumours. Proc R Soc Med (1974) 1.13
Carcinoma of the renal pelvis: a review of 43 cases. Br J Urol (1973) 1.10
Bilateral carcinoma in polycystic renal disease, an unique case. J Urol (1954) 1.04
Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis. Transplant Proc (1971) 1.00
Treatment of bilateral hypernephromas by nephrectomy, excision of tumour, and autotransplantation. Report of three cases. Lancet (1973) 0.88
Observations on experimental and clinical liver transplantation. Transplant Proc (1972) 0.80
Immunosuppression and cancer. Lancet (1969) 0.80
Seminoma and intestitial-cell tumour of the testis. Br J Surg (1968) 0.79
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89
Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation (1979) 5.12
Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J (1968) 4.38
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol (2001) 4.09
Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ (2000) 3.95
Is dialysis hypotension caused by an abnormality of venous tone? Br Med J (Clin Res Ed) (1988) 3.48
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res (1999) 3.36
Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09
Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg (1988) 3.04
Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98
A new technique for biliary drainage in orthotopic liver transplantation utilizing the gall bladder as a pedicle graft conduit between the donor and recipient common bile ducts. Ann Surg (1976) 2.86
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol (1997) 2.75
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet (1978) 2.57
Liver transplantation. Curr Probl Surg (1979) 2.57
Rapamycin for immunosuppression in organ allografting. Lancet (1989) 2.51
Orthotopic liver transplantation: the first 60 patients. Br Med J (1977) 2.50
Soluble HLA antigens in the circulation of liver graft recipients. Transplantation (1989) 2.48
A surgical experience with five hundred thirty liver transplants in the rat. Surgery (1983) 2.48
Some personal observations on the university department of surgery. Ann R Coll Surg Engl (1977) 2.46
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol (2001) 2.24
Prolonged survival of liver transplants in the pig. Br Med J (1967) 2.14
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
Simple hypothermic preservation for transporting human livers long distances for transplantation. Report of 12 cases. Transplantation (1977) 2.08
Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg (1997) 2.00
Liver transplantation in man: the frequency of rejection, biliary tract complications, and recurrence of malignancy based on an analysis of 26 cases. Gastroenterology (1973) 1.99
Transplant surgery: current status. Br J Surg (1980) 1.95
Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94
Bile composition and bile cast formation after transplantation of the liver in man. Transplantation (1975) 1.92
Changes in leucocyte migration after renal transplantation. Br Med J (1969) 1.91
Liver transplantation in 100 children: Cambridge and King's College Hospital series. BMJ (1992) 1.90
Blood loss using the modified two-layer Kiil dialyser. Br Med J (1967) 1.89
Stochastic league tables: communicating cost-effectiveness results to decision-makers. Health Econ (2001) 1.89
Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ (1990) 1.88
Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup. Trop Med Int Health (2001) 1.88
Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg (2001) 1.87
Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation. N Engl J Med (1970) 1.83
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. Ann Surg Oncol (1998) 1.78
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg (1996) 1.77
Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. Abdom Imaging (1996) 1.76
Adrenal cortical carcinoma. World J Surg (2001) 1.74
What are the priorities for prevention and control of non-communicable diseases and injuries in sub-Saharan Africa and South East Asia? BMJ (2012) 1.72
Gastrointestinal complications after renal transplantation. Lancet (1971) 1.71
Pancreatic leak after left pancreatectomy is reduced following main pancreatic duct ligation. Br J Surg (2003) 1.71
Observations of orthotopic liver transplantation in the pig. Br Med J (1967) 1.69
The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas (1996) 1.68
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
Liver transplantation in man. II. A report of two orthotopic liver transplants in adult recipients. Br Med J (1968) 1.68
Liver transplantation. Transplant Rev (1969) 1.67
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. Am J Transplant (2008) 1.67
Outcome of HIV infection in transplant patient on cyclosporin. Lancet (1991) 1.66
Combined mediastinal and retroperitoneal fibrosis. Lancet (1966) 1.66
Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol (2000) 1.65
Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med (1982) 1.64
Cyclosporin A stimulates proliferation of the liver cells after partial hepatectomy in rats. Surg Gynecol Obstet (1988) 1.60
Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery (2001) 1.60
Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet (1988) 1.60
Laparoscopy in the staging of pancreatic cancer. Br J Surg (2001) 1.59
A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol (2000) 1.58
Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. Eur J Pharmacol (1976) 1.57
Differentiation between specific and non-specific hepatitis C antibodies in chronic liver disease. Lancet (1990) 1.57
Administration of heparin and antibiotic prophylaxis. Br J Surg (1994) 1.55
Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bull World Health Organ (2001) 1.55
Cellular immune response during rejection of a liver transplant in man. Nature (1969) 1.55
Association of gastric adenocarcinoma with the HLA class II gene DQB10301. Gastroenterology (1996) 1.54
Observations on preservation, bile drainage and rejection in 64 human orthotopic liver allografts. Ann Surg (1977) 1.53
The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation (1988) 1.51
The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine. Anaesthesia (1987) 1.47
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res (2000) 1.47
Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res (2001) 1.46
Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin. Br Med J (1978) 1.46
Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg (1997) 1.44
The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res (1997) 1.43
Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol (1993) 1.43
Plasma lipids following renal transplantation. Transplantation (1973) 1.42
Adenosine receptors mediating cardiac depression. Life Sci (1982) 1.41
The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology? Med J Aust (1991) 1.40
Successful use of size-mismatched liver allografts in children by delayed primary closure of the abdominal wall. Br J Surg (1996) 1.39
Cadaveric kidneys for transplantation. Br Med J (1969) 1.39
Prolongation of canine pancreas allograft survival with cyclosporin A: preliminary report. Br Med J (1980) 1.38
Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Biochem Pharmacol (1986) 1.37
Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg (1998) 1.35
Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg (1996) 1.35
Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res (1997) 1.34
Immunosuppressive effects of the orthotopically transplanted porcine liver. Transplant Proc (1969) 1.34
Glucose and insulin metabolism after pancreatic transplantation. Br Med J (1972) 1.30
Surgical self-scrutiny. Lancet (1974) 1.29
Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol (1998) 1.29
Liver transplantation for liver cancer. World J Surg (1982) 1.28
Kidney graft survival and matching for HL-A and ABO antigens. Nature (1973) 1.27